Supply of 640,000 doses of the vaccine against herpes zoster for the years 2026 and 2027
About This Opportunity
TranslatedThis contract aims to acquire 640,000 doses of the herpes zoster vaccine for distribution in 2026 and 2027. The vaccine is intended for individuals belonging to nationally agreed-upon target groups who are at risk due to specific health conditions or age, as per the recommendations of the Directorate-General for Public Health included in the lifelong vaccination calendar for the Community of Madrid for 2025. As these supplies fall under Article 16.3.a) of the Public Sector Contracts Law (L.C.S.P.), the quantities proposed for award are estimates. The actual delivery will be contingent upon the needs of the Directorate-General for Public Health. This procurement is essential for the public health strategy to prevent and manage herpes zoster infections within the specified population groups. Bidders are expected to provide proposals that meet the required quality standards and delivery schedules. The tender process will ensure the availability of this critical vaccine to protect vulnerable populations. Further details on technical specifications, evaluation criteria, and submission procedures are available in the full tender documentation.
This is a supplies contract in the health and medical services sector, with a focus on Vaccines. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 77.0 million.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from SpanishThis contract has as its object "The acquisition of 640,000 doses of the vaccine against herpes zoster for the years 2026 and 2027" for the vaccination of people belonging to the target groups agreed at the national level for this disease, either by presenting risk conditions or by indication due to age, and according to the recommendations of the Directorate General of Public Health included in the Lifelong Vaccination Schedule of the Community of Madrid for the year 2025. As these are supplies contemplated in article 16.3.a) of the L.C.S.P., the quantities proposed for award are estimated and their delivery is conditioned to the needs of the Directorate General of Public Health.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 10, 2026. Last refreshed 30 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid has issued 15 procurement notices on BidsFactory, including 0 currently open and 11 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and Environment & Climate. All notices are published for Spain. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: September 4, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to GLAXOSMITHKLINE, S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Consejería de Sanidad de la Comunidad de Madrid in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
GLAXOSMITHKLINE, S.A. was awarded the contract for €80,038,400. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.